FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488895845> ?p ?o ?g. }

• W2488895845 endingPage "e4282" @default.
• W2488895845 startingPage "e4282" @default.
• W2488895845 abstract "Recently, it has been reported that the relative dose intensity (RDI) of adjuvant chemotherapy (AC) influences survival in various cancers, but there are very few reports about RDI in pancreatic ductal adenocarcinoma (PDAC). The optimal timing for initiation of AC for PDAC also remains unknown. The aim of this study was to identify the significance of RDI and the time interval between surgery and initiation of AC on survival of patients with PDAC. Clinicopathological factors that affect RDI were also investigated. A total of 311 consecutive PDAC patients who underwent curative resection between May 2005 and January 2015 were enrolled. Patients who underwent neoadjuvant chemoradiation, had UICC stage IV disease, or had early recurrences within 6 months were excluded, and the remaining 168 cases were analyzed. Patients with RDIs ≥80% (n = 79) showed significantly better overall survival (OS) compared to patients with RDIs <80% (n = 55) (median survival time (MST): 45.6 months, 26.0 months, P < 0.001). Patients with no AC (n = 34) showed the worst OS (MST: 20.8 months). Whether the AC was initiated earlier or later than 8 weeks after surgery did not influence survival, either in patients with RDIs ≥80% (P = 0.79) or in those with <80% (P = 0.73). Patients in the S-1 monotherapy group (n = 49) showed significantly better OS than patients in the gemcitabine monotherapy group (n = 51) (MST: 95.0 months, 26.0 months, respectively; P = 0.001). Univariate analysis conducted after adjusting for the chemotherapeutic drug used identified several prognostic factors; male gender (P = 0.01), intraoperative blood transfusion (P = 0.005), lymph node metastasis (P = 0.03), and postoperative WBC count (P = 0.03). Multivariate analysis identified intra-plus postoperative blood transfusion (P = 0.002) and high postoperative platelet-to-lymphocyte ratios (PLR) (P = 0.04) as independent predictors of poor RDI. Efforts to maintain RDI had a greater impact on survival than the struggle to start AC early after surgery. Intra-plus postoperative blood transfusion and a high postoperative PLR could be predictive markers of reduced RDI in AC of PDAC patients. Avoidance of perioperative blood transfusions where possible and nutritional support during the perioperative period could maintain adequate RDI and may lead to improved long-term outcome." @default.
• W2488895845 created "2016-08-23" @default.
• W2488895845 creator A5018146056 @default.
• W2488895845 creator A5018268432 @default.
• W2488895845 creator A5020304167 @default.
• W2488895845 creator A5022036602 @default.
• W2488895845 creator A5022391772 @default.
• W2488895845 creator A5024357804 @default.
• W2488895845 creator A5026008250 @default.
• W2488895845 creator A5039896704 @default.
• W2488895845 creator A5047606517 @default.
• W2488895845 creator A5087008478 @default.
• W2488895845 date "2016-07-01" @default.
• W2488895845 modified "2023-10-16" @default.
• W2488895845 title "The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity" @default.
• W2488895845 cites W1673961367 @default.
• W2488895845 cites W1852328549 @default.
• W2488895845 cites W1875224590 @default.
• W2488895845 cites W1899541887 @default.
• W2488895845 cites W1974506934 @default.
• W2488895845 cites W1975143971 @default.
• W2488895845 cites W1977678391 @default.
• W2488895845 cites W1984253491 @default.
• W2488895845 cites W1988586429 @default.
• W2488895845 cites W1992458520 @default.
• W2488895845 cites W1992573484 @default.
• W2488895845 cites W2000138167 @default.
• W2488895845 cites W2003211608 @default.
• W2488895845 cites W2005438755 @default.
• W2488895845 cites W2013721841 @default.
• W2488895845 cites W2032044485 @default.
• W2488895845 cites W2036709321 @default.
• W2488895845 cites W2039287295 @default.
• W2488895845 cites W2047318784 @default.
• W2488895845 cites W2058359436 @default.
• W2488895845 cites W2078090242 @default.
• W2488895845 cites W2087007078 @default.
• W2488895845 cites W2092738625 @default.
• W2488895845 cites W2095598060 @default.
• W2488895845 cites W2107398894 @default.
• W2488895845 cites W2107785731 @default.
• W2488895845 cites W2120338564 @default.
• W2488895845 cites W2123781713 @default.
• W2488895845 cites W2129197203 @default.
• W2488895845 cites W2129884672 @default.
• W2488895845 cites W2138582833 @default.
• W2488895845 cites W2140535357 @default.
• W2488895845 cites W2152834195 @default.
• W2488895845 cites W2157590016 @default.
• W2488895845 cites W2313168486 @default.
• W2488895845 cites W2317050565 @default.
• W2488895845 doi "https://doi.org/10.1097/md.0000000000004282" @default.
• W2488895845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5265784" @default.
• W2488895845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27442667" @default.
• W2488895845 hasPublicationYear "2016" @default.
• W2488895845 type Work @default.
• W2488895845 sameAs 2488895845 @default.
• W2488895845 citedByCount "26" @default.
• W2488895845 countsByYear W24888958452018 @default.
• W2488895845 countsByYear W24888958452019 @default.
• W2488895845 countsByYear W24888958452020 @default.
• W2488895845 countsByYear W24888958452021 @default.
• W2488895845 countsByYear W24888958452022 @default.
• W2488895845 countsByYear W24888958452023 @default.
• W2488895845 crossrefType "journal-article" @default.
• W2488895845 hasAuthorship W2488895845A5018146056 @default.
• W2488895845 hasAuthorship W2488895845A5018268432 @default.
• W2488895845 hasAuthorship W2488895845A5020304167 @default.
• W2488895845 hasAuthorship W2488895845A5022036602 @default.
• W2488895845 hasAuthorship W2488895845A5022391772 @default.
• W2488895845 hasAuthorship W2488895845A5024357804 @default.
• W2488895845 hasAuthorship W2488895845A5026008250 @default.
• W2488895845 hasAuthorship W2488895845A5039896704 @default.
• W2488895845 hasAuthorship W2488895845A5047606517 @default.
• W2488895845 hasAuthorship W2488895845A5087008478 @default.
• W2488895845 hasBestOaLocation W24888958451 @default.
• W2488895845 hasConcept C121608353 @default.
• W2488895845 hasConcept C126322002 @default.
• W2488895845 hasConcept C143998085 @default.
• W2488895845 hasConcept C144301174 @default.
• W2488895845 hasConcept C146357865 @default.
• W2488895845 hasConcept C151730666 @default.
• W2488895845 hasConcept C2776694085 @default.
• W2488895845 hasConcept C2777863537 @default.
• W2488895845 hasConcept C2780210213 @default.
• W2488895845 hasConcept C2780258809 @default.
• W2488895845 hasConcept C2781182431 @default.
• W2488895845 hasConcept C2992026798 @default.
• W2488895845 hasConcept C38180746 @default.
• W2488895845 hasConcept C71924100 @default.
• W2488895845 hasConcept C86803240 @default.
• W2488895845 hasConcept C90924648 @default.
• W2488895845 hasConceptScore W2488895845C121608353 @default.
• W2488895845 hasConceptScore W2488895845C126322002 @default.
• W2488895845 hasConceptScore W2488895845C143998085 @default.
• W2488895845 hasConceptScore W2488895845C144301174 @default.
• W2488895845 hasConceptScore W2488895845C146357865 @default.
• W2488895845 hasConceptScore W2488895845C151730666 @default.

• next